G116R (p.Gly116Arg) variant of KRT9 (Keratin, type I cytoskeletal 9)

G116R (p.Gly116Arg) in KRT9 (Keratin, type I cytoskeletal 9) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.54 / 1. The record also includes population frequency data and structural context.

G116R (p.Gly116Arg) variant details